The global market for Acyclovir Intermediate was valued at US$ 41 million in the year 2024 and is projected to reach a revised size of US$ 61.9 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Acyclovir Intermediate Market

An acyclovir intermediate is a chemical compound used in the synthesis of acyclovir, an antiviral drug primarily used to treat herpes simplex and varicella-zoster infections. These intermediates serve as key precursors in the multi-step production process, ensuring the efficient and high-purity synthesis of the final active pharmaceutical ingredient (API).

North American market for Acyclovir Intermediate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Acyclovir Intermediate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Acyclovir Intermediate include Fuxiang Pharmaceuticals, Hubei Yitai Pharmaceuticals Co., Ltd., Shanghai Pharmaceuticals Kangli, Zhejiang Chetou Pharmaceuticals, Tongliao Desheng Bio-tech, Hongyuan Pharmaceuticals, Xinxiang Pharmaceuticals, Zhejiang Oma Pharmaceuticals, Aotong Pharmaceuticals, Manus Aktteva Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Acyclovir Intermediate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acyclovir Intermediate.

The Acyclovir Intermediate market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Acyclovir Intermediate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acyclovir Intermediate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Acyclovir Intermediate Market Report

Report Metric	Details
Report Name	Acyclovir Intermediate Market
Accounted market size in year	US$ 41 million
Forecasted market size in 2031	US$ 61.9 million
CAGR	6.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Diacetylguanine 2,6-Dichloropurine 2-Amino-6-chloropurine Other
Segment by Application	Pharmaceuticals Scientific Research
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Fuxiang Pharmaceuticals, Hubei Yitai Pharmaceuticals Co., Ltd., Shanghai Pharmaceuticals Kangli, Zhejiang Chetou Pharmaceuticals, Tongliao Desheng Bio-tech, Hongyuan Pharmaceuticals, Xinxiang Pharmaceuticals, Zhejiang Oma Pharmaceuticals, Aotong Pharmaceuticals, Manus Aktteva Biopharma, AFINE CHEMICALS, AuroMedics, Hari Pharma, Fresenius Kabi, SteriMax
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acyclovir Intermediate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acyclovir Intermediate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Acyclovir Intermediate Market growing?

Ans: The Acyclovir Intermediate Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Acyclovir Intermediate Market size in 2031?

Ans: The Acyclovir Intermediate Market size in 2031 will be US$ 61.9 million.

Who are the main players in the Acyclovir Intermediate Market report?

Ans: The main players in the Acyclovir Intermediate Market are Fuxiang Pharmaceuticals, Hubei Yitai Pharmaceuticals Co., Ltd., Shanghai Pharmaceuticals Kangli, Zhejiang Chetou Pharmaceuticals, Tongliao Desheng Bio-tech, Hongyuan Pharmaceuticals, Xinxiang Pharmaceuticals, Zhejiang Oma Pharmaceuticals, Aotong Pharmaceuticals, Manus Aktteva Biopharma, AFINE CHEMICALS, AuroMedics, Hari Pharma, Fresenius Kabi, SteriMax

What are the Application segmentation covered in the Acyclovir Intermediate Market report?

Ans: The Applications covered in the Acyclovir Intermediate Market report are Pharmaceuticals, Scientific Research

What are the Type segmentation covered in the Acyclovir Intermediate Market report?

Ans: The Types covered in the Acyclovir Intermediate Market report are Diacetylguanine, 2,6-Dichloropurine, 2-Amino-6-chloropurine, Other

1 Acyclovir Intermediate Market Overview

1.1 Product Definition

1.2 Acyclovir Intermediate by Type

1.2.1 Global Acyclovir Intermediate Market Value Comparison by Type (2024 VS 2031)

1.2.2 Diacetylguanine

1.2.3 2,6-Dichloropurine

1.2.4 2-Amino-6-chloropurine

1.2.5 Other

1.3 Acyclovir Intermediate by Application

1.3.1 Global Acyclovir Intermediate Market Value by Application (2024 VS 2031)

1.3.2 Pharmaceuticals

1.3.3 Scientific Research

1.4 Global Acyclovir Intermediate Market Size Estimates and Forecasts

1.4.1 Global Acyclovir Intermediate Revenue 2020-2031

1.4.2 Global Acyclovir Intermediate Sales 2020-2031

1.4.3 Global Acyclovir Intermediate Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Acyclovir Intermediate Market Competition by Manufacturers

2.1 Global Acyclovir Intermediate Sales Market Share by Manufacturers (2020-2025)

2.2 Global Acyclovir Intermediate Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Acyclovir Intermediate Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Acyclovir Intermediate, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Acyclovir Intermediate, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Acyclovir Intermediate, Product Type & Application

2.7 Global Key Manufacturers of Acyclovir Intermediate, Date of Enter into This Industry

2.8 Global Acyclovir Intermediate Market Competitive Situation and Trends

2.8.1 Global Acyclovir Intermediate Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Acyclovir Intermediate Players Market Share by Revenue

2.8.3 Global Acyclovir Intermediate Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Acyclovir Intermediate Market Scenario by Region

3.1 Global Acyclovir Intermediate Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Acyclovir Intermediate Sales by Region: 2020-2031

3.2.1 Global Acyclovir Intermediate Sales by Region: 2020-2025

3.2.2 Global Acyclovir Intermediate Sales by Region: 2026-2031

3.3 Global Acyclovir Intermediate Revenue by Region: 2020-2031

3.3.1 Global Acyclovir Intermediate Revenue by Region: 2020-2025

3.3.2 Global Acyclovir Intermediate Revenue by Region: 2026-2031

3.4 North America Acyclovir Intermediate Market Facts & Figures by Country

3.4.1 North America Acyclovir Intermediate Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Acyclovir Intermediate Sales by Country (2020-2031)

3.4.3 North America Acyclovir Intermediate Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Acyclovir Intermediate Market Facts & Figures by Country

3.5.1 Europe Acyclovir Intermediate Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Acyclovir Intermediate Sales by Country (2020-2031)

3.5.3 Europe Acyclovir Intermediate Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Acyclovir Intermediate Market Facts & Figures by Region

3.6.1 Asia Pacific Acyclovir Intermediate Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Acyclovir Intermediate Sales by Region (2020-2031)

3.6.3 Asia Pacific Acyclovir Intermediate Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Acyclovir Intermediate Market Facts & Figures by Country

3.7.1 Latin America Acyclovir Intermediate Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Acyclovir Intermediate Sales by Country (2020-2031)

3.7.3 Latin America Acyclovir Intermediate Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Acyclovir Intermediate Market Facts & Figures by Country

3.8.1 Middle East and Africa Acyclovir Intermediate Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Acyclovir Intermediate Sales by Country (2020-2031)

3.8.3 Middle East and Africa Acyclovir Intermediate Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Acyclovir Intermediate Sales by Type (2020-2031)

4.1.1 Global Acyclovir Intermediate Sales by Type (2020-2025)

4.1.2 Global Acyclovir Intermediate Sales by Type (2026-2031)

4.1.3 Global Acyclovir Intermediate Sales Market Share by Type (2020-2031)

4.2 Global Acyclovir Intermediate Revenue by Type (2020-2031)

4.2.1 Global Acyclovir Intermediate Revenue by Type (2020-2025)

4.2.2 Global Acyclovir Intermediate Revenue by Type (2026-2031)

4.2.3 Global Acyclovir Intermediate Revenue Market Share by Type (2020-2031)

4.3 Global Acyclovir Intermediate Price by Type (2020-2031)

5 Segment by Application

5.1 Global Acyclovir Intermediate Sales by Application (2020-2031)

5.1.1 Global Acyclovir Intermediate Sales by Application (2020-2025)

5.1.2 Global Acyclovir Intermediate Sales by Application (2026-2031)

5.1.3 Global Acyclovir Intermediate Sales Market Share by Application (2020-2031)

5.2 Global Acyclovir Intermediate Revenue by Application (2020-2031)

5.2.1 Global Acyclovir Intermediate Revenue by Application (2020-2025)

5.2.2 Global Acyclovir Intermediate Revenue by Application (2026-2031)

5.2.3 Global Acyclovir Intermediate Revenue Market Share by Application (2020-2031)

5.3 Global Acyclovir Intermediate Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Fuxiang Pharmaceuticals

6.1.1 Fuxiang Pharmaceuticals Company Information

6.1.2 Fuxiang Pharmaceuticals Description and Business Overview

6.1.3 Fuxiang Pharmaceuticals Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Fuxiang Pharmaceuticals Acyclovir Intermediate Product Portfolio

6.1.5 Fuxiang Pharmaceuticals Recent Developments/Updates

6.2 Hubei Yitai Pharmaceuticals Co., Ltd.

6.2.1 Hubei Yitai Pharmaceuticals Co., Ltd. Company Information

6.2.2 Hubei Yitai Pharmaceuticals Co., Ltd. Description and Business Overview

6.2.3 Hubei Yitai Pharmaceuticals Co., Ltd. Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Hubei Yitai Pharmaceuticals Co., Ltd. Acyclovir Intermediate Product Portfolio

6.2.5 Hubei Yitai Pharmaceuticals Co., Ltd. Recent Developments/Updates

6.3 Shanghai Pharmaceuticals Kangli

6.3.1 Shanghai Pharmaceuticals Kangli Company Information

6.3.2 Shanghai Pharmaceuticals Kangli Description and Business Overview

6.3.3 Shanghai Pharmaceuticals Kangli Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Shanghai Pharmaceuticals Kangli Acyclovir Intermediate Product Portfolio

6.3.5 Shanghai Pharmaceuticals Kangli Recent Developments/Updates

6.4 Zhejiang Chetou Pharmaceuticals

6.4.1 Zhejiang Chetou Pharmaceuticals Company Information

6.4.2 Zhejiang Chetou Pharmaceuticals Description and Business Overview

6.4.3 Zhejiang Chetou Pharmaceuticals Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Zhejiang Chetou Pharmaceuticals Acyclovir Intermediate Product Portfolio

6.4.5 Zhejiang Chetou Pharmaceuticals Recent Developments/Updates

6.5 Tongliao Desheng Bio-tech

6.5.1 Tongliao Desheng Bio-tech Company Information

6.5.2 Tongliao Desheng Bio-tech Description and Business Overview

6.5.3 Tongliao Desheng Bio-tech Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Tongliao Desheng Bio-tech Acyclovir Intermediate Product Portfolio

6.5.5 Tongliao Desheng Bio-tech Recent Developments/Updates

6.6 Hongyuan Pharmaceuticals

6.6.1 Hongyuan Pharmaceuticals Company Information

6.6.2 Hongyuan Pharmaceuticals Description and Business Overview

6.6.3 Hongyuan Pharmaceuticals Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Hongyuan Pharmaceuticals Acyclovir Intermediate Product Portfolio

6.6.5 Hongyuan Pharmaceuticals Recent Developments/Updates

6.7 Xinxiang Pharmaceuticals

6.7.1 Xinxiang Pharmaceuticals Company Information

6.7.2 Xinxiang Pharmaceuticals Description and Business Overview

6.7.3 Xinxiang Pharmaceuticals Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Xinxiang Pharmaceuticals Acyclovir Intermediate Product Portfolio

6.7.5 Xinxiang Pharmaceuticals Recent Developments/Updates

6.8 Zhejiang Oma Pharmaceuticals

6.8.1 Zhejiang Oma Pharmaceuticals Company Information

6.8.2 Zhejiang Oma Pharmaceuticals Description and Business Overview

6.8.3 Zhejiang Oma Pharmaceuticals Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Zhejiang Oma Pharmaceuticals Acyclovir Intermediate Product Portfolio

6.8.5 Zhejiang Oma Pharmaceuticals Recent Developments/Updates

6.9 Aotong Pharmaceuticals

6.9.1 Aotong Pharmaceuticals Company Information

6.9.2 Aotong Pharmaceuticals Description and Business Overview

6.9.3 Aotong Pharmaceuticals Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Aotong Pharmaceuticals Acyclovir Intermediate Product Portfolio

6.9.5 Aotong Pharmaceuticals Recent Developments/Updates

6.10 Manus Aktteva Biopharma

6.10.1 Manus Aktteva Biopharma Company Information

6.10.2 Manus Aktteva Biopharma Description and Business Overview

6.10.3 Manus Aktteva Biopharma Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Manus Aktteva Biopharma Acyclovir Intermediate Product Portfolio

6.10.5 Manus Aktteva Biopharma Recent Developments/Updates

6.11 AFINE CHEMICALS

6.11.1 AFINE CHEMICALS Company Information

6.11.2 AFINE CHEMICALS Description and Business Overview

6.11.3 AFINE CHEMICALS Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.11.4 AFINE CHEMICALS Acyclovir Intermediate Product Portfolio

6.11.5 AFINE CHEMICALS Recent Developments/Updates

6.12 AuroMedics

6.12.1 AuroMedics Company Information

6.12.2 AuroMedics Description and Business Overview

6.12.3 AuroMedics Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.12.4 AuroMedics Acyclovir Intermediate Product Portfolio

6.12.5 AuroMedics Recent Developments/Updates

6.13 Hari Pharma

6.13.1 Hari Pharma Company Information

6.13.2 Hari Pharma Description and Business Overview

6.13.3 Hari Pharma Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Hari Pharma Acyclovir Intermediate Product Portfolio

6.13.5 Hari Pharma Recent Developments/Updates

6.14 Fresenius Kabi

6.14.1 Fresenius Kabi Company Information

6.14.2 Fresenius Kabi Description and Business Overview

6.14.3 Fresenius Kabi Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Fresenius Kabi Acyclovir Intermediate Product Portfolio

6.14.5 Fresenius Kabi Recent Developments/Updates

6.15 SteriMax

6.15.1 SteriMax Company Information

6.15.2 SteriMax Description and Business Overview

6.15.3 SteriMax Acyclovir Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.15.4 SteriMax Acyclovir Intermediate Product Portfolio

6.15.5 SteriMax Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Acyclovir Intermediate Industry Chain Analysis

7.2 Acyclovir Intermediate Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Acyclovir Intermediate Production Mode & Process Analysis

7.4 Acyclovir Intermediate Sales and Marketing

7.4.1 Acyclovir Intermediate Sales Channels

7.4.2 Acyclovir Intermediate Distributors

7.5 Acyclovir Intermediate Customer Analysis

8 Acyclovir Intermediate Market Dynamics

8.1 Acyclovir Intermediate Industry Trends

8.2 Acyclovir Intermediate Market Drivers

8.3 Acyclovir Intermediate Market Challenges

8.4 Acyclovir Intermediate Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Fuxiang Pharmaceuticals

Tongliao Desheng Bio-tech

Manus Aktteva Biopharma

Hubei Yitai Pharmaceuticals Co., Ltd.

Shanghai Pharmaceuticals Kangli

Zhejiang Chetou Pharmaceuticals

Hongyuan Pharmaceuticals

Xinxiang Pharmaceuticals

Zhejiang Oma Pharmaceuticals

Aotong Pharmaceuticals

List of Tables

Table 1. Global Acyclovir Intermediate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Acyclovir Intermediate Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Acyclovir Intermediate Market Competitive Situation by Manufacturers in 2024

Table 4. Global Acyclovir Intermediate Sales (Tons) of Key Manufacturers (2020-2025)

Table 5. Global Acyclovir Intermediate Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Acyclovir Intermediate Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Acyclovir Intermediate Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Acyclovir Intermediate Average Price (US$/Ton) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Acyclovir Intermediate, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Acyclovir Intermediate, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Acyclovir Intermediate, Product Type & Application

Table 12. Global Key Manufacturers of Acyclovir Intermediate, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Acyclovir Intermediate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acyclovir Intermediate as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Acyclovir Intermediate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Acyclovir Intermediate Sales by Region (2020-2025) & (Tons)

Table 18. Global Acyclovir Intermediate Sales Market Share by Region (2020-2025)

Table 19. Global Acyclovir Intermediate Sales by Region (2026-2031) & (Tons)

Table 20. Global Acyclovir Intermediate Sales Market Share by Region (2026-2031)

Table 21. Global Acyclovir Intermediate Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Acyclovir Intermediate Revenue Market Share by Region (2020-2025)

Table 23. Global Acyclovir Intermediate Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Acyclovir Intermediate Revenue Market Share by Region (2026-2031)

Table 25. North America Acyclovir Intermediate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Acyclovir Intermediate Sales by Country (2020-2025) & (Tons)

Table 27. North America Acyclovir Intermediate Sales by Country (2026-2031) & (Tons)

Table 28. North America Acyclovir Intermediate Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Acyclovir Intermediate Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Acyclovir Intermediate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Acyclovir Intermediate Sales by Country (2020-2025) & (Tons)

Table 32. Europe Acyclovir Intermediate Sales by Country (2026-2031) & (Tons)

Table 33. Europe Acyclovir Intermediate Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Acyclovir Intermediate Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Acyclovir Intermediate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Acyclovir Intermediate Sales by Region (2020-2025) & (Tons)

Table 37. Asia Pacific Acyclovir Intermediate Sales by Region (2026-2031) & (Tons)

Table 38. Asia Pacific Acyclovir Intermediate Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Acyclovir Intermediate Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Acyclovir Intermediate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Acyclovir Intermediate Sales by Country (2020-2025) & (Tons)

Table 42. Latin America Acyclovir Intermediate Sales by Country (2026-2031) & (Tons)

Table 43. Latin America Acyclovir Intermediate Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Acyclovir Intermediate Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Acyclovir Intermediate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Acyclovir Intermediate Sales by Country (2020-2025) & (Tons)

Table 47. Middle East and Africa Acyclovir Intermediate Sales by Country (2026-2031) & (Tons)

Table 48. Middle East and Africa Acyclovir Intermediate Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Acyclovir Intermediate Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Acyclovir Intermediate Sales (Tons) by Type (2020-2025)

Table 51. Global Acyclovir Intermediate Sales (Tons) by Type (2026-2031)

Table 52. Global Acyclovir Intermediate Sales Market Share by Type (2020-2025)

Table 53. Global Acyclovir Intermediate Sales Market Share by Type (2026-2031)

Table 54. Global Acyclovir Intermediate Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Acyclovir Intermediate Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Acyclovir Intermediate Revenue Market Share by Type (2020-2025)

Table 57. Global Acyclovir Intermediate Revenue Market Share by Type (2026-2031)

Table 58. Global Acyclovir Intermediate Price (US$/Ton) by Type (2020-2025)

Table 59. Global Acyclovir Intermediate Price (US$/Ton) by Type (2026-2031)

Table 60. Global Acyclovir Intermediate Sales (Tons) by Application (2020-2025)

Table 61. Global Acyclovir Intermediate Sales (Tons) by Application (2026-2031)

Table 62. Global Acyclovir Intermediate Sales Market Share by Application (2020-2025)

Table 63. Global Acyclovir Intermediate Sales Market Share by Application (2026-2031)

Table 64. Global Acyclovir Intermediate Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Acyclovir Intermediate Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Acyclovir Intermediate Revenue Market Share by Application (2020-2025)

Table 67. Global Acyclovir Intermediate Revenue Market Share by Application (2026-2031)

Table 68. Global Acyclovir Intermediate Price (US$/Ton) by Application (2020-2025)

Table 69. Global Acyclovir Intermediate Price (US$/Ton) by Application (2026-2031)

Table 70. Fuxiang Pharmaceuticals Company Information

Table 71. Fuxiang Pharmaceuticals Description and Business Overview

Table 72. Fuxiang Pharmaceuticals Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Fuxiang Pharmaceuticals Acyclovir Intermediate Product

Table 74. Fuxiang Pharmaceuticals Recent Developments/Updates

Table 75. Hubei Yitai Pharmaceuticals Co., Ltd. Company Information

Table 76. Hubei Yitai Pharmaceuticals Co., Ltd. Description and Business Overview

Table 77. Hubei Yitai Pharmaceuticals Co., Ltd. Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. Hubei Yitai Pharmaceuticals Co., Ltd. Acyclovir Intermediate Product

Table 79. Hubei Yitai Pharmaceuticals Co., Ltd. Recent Developments/Updates

Table 80. Shanghai Pharmaceuticals Kangli Company Information

Table 81. Shanghai Pharmaceuticals Kangli Description and Business Overview

Table 82. Shanghai Pharmaceuticals Kangli Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Shanghai Pharmaceuticals Kangli Acyclovir Intermediate Product

Table 84. Shanghai Pharmaceuticals Kangli Recent Developments/Updates

Table 85. Zhejiang Chetou Pharmaceuticals Company Information

Table 86. Zhejiang Chetou Pharmaceuticals Description and Business Overview

Table 87. Zhejiang Chetou Pharmaceuticals Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Zhejiang Chetou Pharmaceuticals Acyclovir Intermediate Product

Table 89. Zhejiang Chetou Pharmaceuticals Recent Developments/Updates

Table 90. Tongliao Desheng Bio-tech Company Information

Table 91. Tongliao Desheng Bio-tech Description and Business Overview

Table 92. Tongliao Desheng Bio-tech Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Tongliao Desheng Bio-tech Acyclovir Intermediate Product

Table 94. Tongliao Desheng Bio-tech Recent Developments/Updates

Table 95. Hongyuan Pharmaceuticals Company Information

Table 96. Hongyuan Pharmaceuticals Description and Business Overview

Table 97. Hongyuan Pharmaceuticals Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Hongyuan Pharmaceuticals Acyclovir Intermediate Product

Table 99. Hongyuan Pharmaceuticals Recent Developments/Updates

Table 100. Xinxiang Pharmaceuticals Company Information

Table 101. Xinxiang Pharmaceuticals Description and Business Overview

Table 102. Xinxiang Pharmaceuticals Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. Xinxiang Pharmaceuticals Acyclovir Intermediate Product

Table 104. Xinxiang Pharmaceuticals Recent Developments/Updates

Table 105. Zhejiang Oma Pharmaceuticals Company Information

Table 106. Zhejiang Oma Pharmaceuticals Description and Business Overview

Table 107. Zhejiang Oma Pharmaceuticals Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. Zhejiang Oma Pharmaceuticals Acyclovir Intermediate Product

Table 109. Zhejiang Oma Pharmaceuticals Recent Developments/Updates

Table 110. Aotong Pharmaceuticals Company Information

Table 111. Aotong Pharmaceuticals Description and Business Overview

Table 112. Aotong Pharmaceuticals Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. Aotong Pharmaceuticals Acyclovir Intermediate Product

Table 114. Aotong Pharmaceuticals Recent Developments/Updates

Table 115. Manus Aktteva Biopharma Company Information

Table 116. Manus Aktteva Biopharma Description and Business Overview

Table 117. Manus Aktteva Biopharma Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. Manus Aktteva Biopharma Acyclovir Intermediate Product

Table 119. Manus Aktteva Biopharma Recent Developments/Updates

Table 120. AFINE CHEMICALS Company Information

Table 121. AFINE CHEMICALS Description and Business Overview

Table 122. AFINE CHEMICALS Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 123. AFINE CHEMICALS Acyclovir Intermediate Product

Table 124. AFINE CHEMICALS Recent Developments/Updates

Table 125. AuroMedics Company Information

Table 126. AuroMedics Description and Business Overview

Table 127. AuroMedics Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 128. AuroMedics Acyclovir Intermediate Product

Table 129. AuroMedics Recent Developments/Updates

Table 130. Hari Pharma Company Information

Table 131. Hari Pharma Description and Business Overview

Table 132. Hari Pharma Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 133. Hari Pharma Acyclovir Intermediate Product

Table 134. Hari Pharma Recent Developments/Updates

Table 135. Fresenius Kabi Company Information

Table 136. Fresenius Kabi Description and Business Overview

Table 137. Fresenius Kabi Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 138. Fresenius Kabi Acyclovir Intermediate Product

Table 139. Fresenius Kabi Recent Developments/Updates

Table 140. SteriMax Company Information

Table 141. SteriMax Description and Business Overview

Table 142. SteriMax Acyclovir Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 143. SteriMax Acyclovir Intermediate Product

Table 144. SteriMax Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Acyclovir Intermediate Distributors List

Table 148. Acyclovir Intermediate Customers List

Table 149. Acyclovir Intermediate Market Trends

Table 150. Acyclovir Intermediate Market Drivers

Table 151. Acyclovir Intermediate Market Challenges

Table 152. Acyclovir Intermediate Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of Acyclovir Intermediate

Figure 2. Global Acyclovir Intermediate Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Acyclovir Intermediate Market Share by Type: 2024 & 2031

Figure 4. Diacetylguanine Product Picture

Figure 5. 2,6-Dichloropurine Product Picture

Figure 6. 2-Amino-6-chloropurine Product Picture

Figure 7. Other Product Picture

Figure 8. Global Acyclovir Intermediate Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Acyclovir Intermediate Market Share by Application: 2024 & 2031

Figure 10. Pharmaceuticals

Figure 11. Scientific Research

Figure 12. Global Acyclovir Intermediate Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Acyclovir Intermediate Market Size (2020-2031) & (US$ Million)

Figure 14. Global Acyclovir Intermediate Sales (2020-2031) & (Tons)

Figure 15. Global Acyclovir Intermediate Average Price (US$/Ton) & (2020-2031)

Figure 16. Acyclovir Intermediate Report Years Considered

Figure 17. Acyclovir Intermediate Sales Share by Manufacturers in 2024

Figure 18. Global Acyclovir Intermediate Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Acyclovir Intermediate Players: Market Share by Revenue in Acyclovir Intermediate in 2024

Figure 20. Acyclovir Intermediate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Acyclovir Intermediate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Acyclovir Intermediate Sales Market Share by Country (2020-2031)

Figure 23. North America Acyclovir Intermediate Revenue Market Share by Country (2020-2031)

Figure 24. United States Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Acyclovir Intermediate Sales Market Share by Country (2020-2031)

Figure 27. Europe Acyclovir Intermediate Revenue Market Share by Country (2020-2031)

Figure 28. Germany Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Acyclovir Intermediate Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Acyclovir Intermediate Revenue Market Share by Region (2020-2031)

Figure 35. China Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Acyclovir Intermediate Sales Market Share by Country (2020-2031)

Figure 43. Latin America Acyclovir Intermediate Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Acyclovir Intermediate Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Acyclovir Intermediate Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Acyclovir Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Acyclovir Intermediate by Type (2020-2031)

Figure 54. Global Revenue Market Share of Acyclovir Intermediate by Type (2020-2031)

Figure 55. Global Acyclovir Intermediate Price (US$/Ton) by Type (2020-2031)

Figure 56. Global Sales Market Share of Acyclovir Intermediate by Application (2020-2031)

Figure 57. Global Revenue Market Share of Acyclovir Intermediate by Application (2020-2031)

Figure 58. Global Acyclovir Intermediate Price (US$/Ton) by Application (2020-2031)

Figure 59. Acyclovir Intermediate Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Diacetylacyclovir Market Research Report 2025

Global Acyclovir Active Pharmaceutical Ingredient API Market Research Report 2025

Global Acyclovir Analogues Market Research Report 2025

Global Acyclovir for Injection Market Research Report 2024

Global Aciclovir Market Research Report 2024

Global Valacyclovir API Market Research Report 2025

Global Acyclovir Injection Market Research Report 2024

Acyclovir Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ritonavir Intermediates Market Research Report 2024

Global Lovir Drug Intermediate Market Research Report 2025

Global Anti Herpesvirus Drug Market Research Report 2025

Valaciclovir HCl Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dolutegravir Intermediates Market Research Report 2024

Global Acyclovir API Market Research Report 2025

Global N 2 9 Diacetylguanine Market Research Report 2025

Global Cephalosporin Intermediates Market Research Report 2025

Global Acyclovir Ointment Market Research Report 2025

Global Valacyclovir Hcl API Market Research Report 2025

Global Penicillin Intermediate Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions